Development Of A Plasma-Derived Polyclonal Antibody-Based Covid-19 Therapeutic

SPX-095368

, Maryland

Project ID: SPX-095368
Estimated value: $15.5M
Square footage: Not reported
Opened / announced: Apr 2, 2020
Owner: Department of Health and Human Services
General contractor: EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC
Architect: Not reported
Brands mentioned: None in public seed

Project overview

DEVELOPMENT OF A PLASMA-DERIVED POLYCLONAL ANTIBODY-BASED COVID-19 THERAPEUTIC. Awarded by Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services). Period of performance through 2021-11-01.

Key specs

Award 75A50120F33006
Awarding agency: Office of Assistant Secretary for Preparedness and Response
ZIP 21224

Still open for manufacturers

Completed federal contract (period of performance has ended). Not an active spec window -- useful for GC/agency relationship history and competitor-win tracking only.

Manufacturer watch list

hvac
roofing
lighting
concrete

Timeline

Awarded
Apr 2, 2020 · Federal (SAM.gov / USAspending)

Run a brand check for this project Back to all projects

Priority score

Low signal

33/100

Value: 33/40
Recency: 0/35
News coverage: 0/25

📍 Regional location pending

Exact coordinates for this project haven't been geocoded yet.